Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Weckesser

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2011
Contribution of PET/CT to prediction of outcome in children and young adults with rhabdomyosarcomaSven H Baum, Michael Frühwald, Kambiz Rahbar, et al.
Deutsches Arzteblatt International|January 9, 2014
Cerebral metastases from thyroid carcinoma: complete remission following radioiodine treatmentAlexis Vrachimis, Kurt Werner Schmid, Heribert Jürgens, et al.
AJR. American Journal of Roentgenology|September 23, 2010
Measurement accuracy and reproducibility of semiautomated metric and volumetric lymph node analysis in MDCTBoris Buerke, Michael Puesken, Stephan Müter, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 9, 2004
Early effects of irradiation on [(123)I]-IMT and [(18)F]-FDG uptake in rat C6 glioma cellsBurkhard Riemann, Stefan Könemann, Daniel Pöpping, et al.
Theranostics|August 15, 2019
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving <sup>177</sup>Lu-PSMA-617Katharina Kessel, Robert Seifert, Michael Schäfers, et al.
Clinical Nuclear Medicine|April 19, 2016
Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate CancerKambiz Rahbar, Axel Bode, Matthias Weckesser, et al.
Minerva Anestesiologica|November 4, 2016
Analysis of cerebral glucose metabolism in patients with post-operative cognitive dysfunctionJan M Herter, Niko Brenscheid, Lydia Nienhaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CTChristiane Franzius, Klaudia Hermann, Matthias Weckesser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2015
[(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancerAlexis Vrachimis, Matthias Christian Burg, Christian Wenning, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2018
Diagnostic performance of <sup>18</sup>F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancerKambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2011
Contribution of PET/CT to prediction of outcome in children and young adults with rhabdomyosarcomaSven H Baum, Michael Frühwald, Kambiz Rahbar, et al.
Deutsches Arzteblatt International|January 9, 2014
Cerebral metastases from thyroid carcinoma: complete remission following radioiodine treatmentAlexis Vrachimis, Kurt Werner Schmid, Heribert Jürgens, et al.
AJR. American Journal of Roentgenology|September 23, 2010
Measurement accuracy and reproducibility of semiautomated metric and volumetric lymph node analysis in MDCTBoris Buerke, Michael Puesken, Stephan Müter, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 9, 2004
Early effects of irradiation on [(123)I]-IMT and [(18)F]-FDG uptake in rat C6 glioma cellsBurkhard Riemann, Stefan Könemann, Daniel Pöpping, et al.
Theranostics|August 15, 2019
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving <sup>177</sup>Lu-PSMA-617Katharina Kessel, Robert Seifert, Michael Schäfers, et al.
Clinical Nuclear Medicine|April 19, 2016
Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate CancerKambiz Rahbar, Axel Bode, Matthias Weckesser, et al.
Minerva Anestesiologica|November 4, 2016
Analysis of cerebral glucose metabolism in patients with post-operative cognitive dysfunctionJan M Herter, Niko Brenscheid, Lydia Nienhaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CTChristiane Franzius, Klaudia Hermann, Matthias Weckesser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2015
[(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancerAlexis Vrachimis, Matthias Christian Burg, Christian Wenning, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2018
Diagnostic performance of <sup>18</sup>F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancerKambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, et al.
Pageof 10